A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion.docVIP

BMC Clinical Pharmacology BioMedCentral Research article Open Access A Phase 1 Trial of pharmacologic interactions between transdermal selegiline and a 4-hour cocaine infusion Debra S Harris*1,2, Thomas Everhart3, Peyton Jacob III3, Emil Lin4, John E Mendelson5 and Reese T Jones3 Address: 1Department of Psychiatry, University of Cincinnati, OH, USA, 2Cincinnati VA Medical Center, OH 45220, USA, 3Drug Dependence Research Center, University of California, San Francisco, USA, 4Drug Studies Unit, University of California, San Francisco, USA and 5Addiction Pharmacology Research Laboratory, Ca